
Utilization of the LACE score to predict 30-day hospital readmission or death in gynecologic oncology patients
Publication
, Conference
Watson, C; Moss, HA; Truong, T; Havrilesky, L
Published in: Gynecologic Oncology
June 2019
Duke Scholars
Published In
Gynecologic Oncology
DOI
ISSN
0090-8258
Publication Date
June 2019
Volume
154
Start / End Page
215 / 215
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Watson, C., Moss, H. A., Truong, T., & Havrilesky, L. (2019). Utilization of the LACE score to predict 30-day hospital readmission or death in gynecologic oncology patients. In Gynecologic Oncology (Vol. 154, pp. 215–215). Elsevier BV. https://doi.org/10.1016/j.ygyno.2019.04.498
Watson, C., H. A. Moss, T. Truong, and L. Havrilesky. “Utilization of the LACE score to predict 30-day hospital readmission or death in gynecologic oncology patients.” In Gynecologic Oncology, 154:215–215. Elsevier BV, 2019. https://doi.org/10.1016/j.ygyno.2019.04.498.
Watson C, Moss HA, Truong T, Havrilesky L. Utilization of the LACE score to predict 30-day hospital readmission or death in gynecologic oncology patients. In: Gynecologic Oncology. Elsevier BV; 2019. p. 215–215.
Watson, C., et al. “Utilization of the LACE score to predict 30-day hospital readmission or death in gynecologic oncology patients.” Gynecologic Oncology, vol. 154, Elsevier BV, 2019, pp. 215–215. Crossref, doi:10.1016/j.ygyno.2019.04.498.
Watson C, Moss HA, Truong T, Havrilesky L. Utilization of the LACE score to predict 30-day hospital readmission or death in gynecologic oncology patients. Gynecologic Oncology. Elsevier BV; 2019. p. 215–215.

Published In
Gynecologic Oncology
DOI
ISSN
0090-8258
Publication Date
June 2019
Volume
154
Start / End Page
215 / 215
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis